This review provides insights into the role of the IL-33-ST2 signaling pathway in sepsis, asthma, and chronic pulmonary obstructive disease and identifies potential therapeutic targets to provide a more reliable basis for disease treatment than is in the literature (Fig. 1). This evidence concerns the gene IL1RL1 and Sepsis.